CFO transition
VitaSpring Biomedical Co. Ltd. CFO transition: Jing-Zhou Chen to succeed Ssu-Chuan Lai
VitaSpring Biomedical Co. Ltd. reported in a Form 8-K filed September 10, 2026 that Jing-Zhou Chen will succeed Ssu-Chuan Lai as Chief Executive Officer, President, Chief Financial Officer, and Secretary, effective September 7, 2026.
In the filing's words
Effective at 11:57 p.m. Pacific Time on September 7, 2026, Dr. Ssu-Chuan Lai, as the sole director then in office, appointed Jing-Zhou Chen as the Company’s Chief Executive Officer, President, Chief Financial Officer, and Secretary, to serve at the pleasure of the Board and until his successor is duly appointed and qualified, or until his earlier death, resignation or removal.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | VitaSpring Biomedical Co. Ltd. (VSBC) |
|---|---|
| Event | Transition |
| Incoming | Jing-Zhou Chen |
| Outgoing | Ssu-Chuan Lai |
| Title in the filing | Chief Executive Officer, President, Chief Financial Officer, and Secretary |
| Effective | September 7, 2026 |
| 8-K filed | September 10, 2026 |
| Internal promotion | No |
| Prior role (per filing) | founder and Chief Executive Officer, Dream Born Co., Ltd. |
| SEC CIK | 0001697884 |
VitaSpring Biomedical Co. Ltd. reported this change in a Form 8-K, Item 5.02, filed September 10, 2026. The filing's own words are quoted above.
Other records naming Ssu-Chuan Lai
1The outgoing officer on this record, matched by name. Career line.
2026-06-17 · 10-K signature
Ssu-Chuan Lai signed VitaSpring Biomedical Co. Ltd.'s annual report as Director, President and Chief Executive Officer (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)
Other records naming Jing-Zhou Chen
1The incoming officer on this record, matched by name. Career line.
2 months ago· 2026-09-02AppointmentACBM
Acro Biomedical Co., Ltd. appoints Jing-Zhou Chen as CFO
Also filed in September 2026
Other CFO moves on the record that month. All moves.
6 weeks ago· 2026-09-30InterimACI
Albertsons Companies, Inc. names Cody Perdue interim CFO
6 weeks ago· 2026-09-30DepartureALDA
Atlantica Inc. discloses CFO departure: Shelley Goff
6 weeks ago· 2026-09-30TransitionCARL
Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein
6 weeks ago· 2026-09-30AppointmentLEVI
Levi Strauss & Co. appoints John Vandemore as CFO
6 weeks ago· 2026-09-30DeparturePTPI
Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein
6 weeks ago· 2026-09-30DepartureTCRX
TScan Therapeutics, Inc. discloses CFO departure: Jason A. Amello
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Jing-Zhou Chen? Send a correction with the primary source.